Press Release: Renova Therapeutics : Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Renova Therapeutics: Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus

Renova Therapeutics: Renova Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

Renova Therapeutics: Renova Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250

Press Release: Renova Therapeutics : Renova Therapeutics Announces an Abstract to be Presented at the Late-Breaking Scientific Session of 2018 American Diabetes Association Meeting: Urocortin-2 Gene Transfer Effectively Treats Type 1 Diabetes

Renova Therapeutics: Renova Therapeutics: JACC: Basic to Translational Science publishes article comparing effects of urocortin 2 versus urocortin 3 gene transfer on left ventricular function and glucose disposal

Renova Therapeutics: Renova Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

Press Release: Renova Therapeutics : Renova Therapeutics Announces Issuance of Patent Covering Delivery and Expression of Paracrine Genes

Renova Therapeutics: Renova Therapeutics to present key components of FLOURISH gene therapy trial for the treatment of heart failure at Keystone Symposium

Renova Therapeutics: Renova Therapeutics' Drug Receives FDA Fast Track Status